// App-Quantinova.ai

OC 03.4 : Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems

Researchers

Presenter

  • L. Hardy

Principal Investigators

  • D. Bohinc

  • K. Bane

  • S. Heal

  • E. Hethershaw

  • M. Ali

  • R. Foster

  • C. Longstaff

  • T. Renne

  • H. Philippou

Medical Centers

  • Leeds Institute of Cardiovascular & Metabolic Medicine (LICAMM), University of Leeds, Leeds, West Yorkshire, United Kingdom, Leeds, England, United Kingdom

  • Case Western Reserve University, Cleveland, Ohio, United States

  • NYU School of Medicine Cleveland OH United States

  • University of Leeds, Leeds, United Kingdom

  • University of Leeds, Leeds, United Kingdom

  • National Institute for Biological Standards and Control, Potters Bar, United Kingdom

  • Institute for Clinical Chemistry and Laboratory Medicine, Eppendorf, Hamburg, Germany

  • Case Western Reserve University School of Medicine, Cleveland, OH

Locations

  • United Kingdom

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Type 2 diabetes mellitus

Biomarkers

  • Human albumin

Drug/Treatment

  • Human serum albumin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved